Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01931527 · ClinicalTrials.gov registry record · NA
Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT01931527 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 31 participants.
The verdict
NCT01931527, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about what is the effect of uric acid on oxidative stress and on the way the body metabolizes sugar in obese people. Understanding this may lead to better diseases such as diabetes.
Interventions
- DRUG Rasburicase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2006-07 |
| Est. Completion | 2012-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01931527
The ClinicalTrials.gov registry entry for NCT01931527 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rasburicase is the first listed.
NCT01931527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01931527 about?
NCT01931527 is a clinical study titled "Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status". The purpose of this study is to learn more about what is the effect of uric acid on oxidative stress and on the way the body metabolizes sugar in obese people. Understanding this may lead to better diseases such as diabetes.
What is the current status of trial NCT01931527?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2006-07. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01931527?
The interventions under investigation include: Rasburicase (DRUG).
Who is sponsoring clinical trial NCT01931527?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.